Accelagen Pty Ltd
Accelagen is a leading global contract research organisation (CRO), co-creating meaningful outcomes that have a tangible impact on the future of human health.
Locations
- APAC
- Australia
- Europe
- North America
Therapeutic Areas
- Bone / Osteoporosis
- Cardiovascular
- CNS
- Dental and Oral Health
- Dermatology
- Devices and Diagnostics
- Diabetes
- Endocrinology
- Gastroenterology
- Genetic Diseases
- Hematology
- Hepatology
- Immunology
- Infectious Diseases
- Inflammation
- Internal Diseases
- Metabolic Diseases
- Musculoskeletal
- Nephrology
- Neurology
- Nutrition and Health
- Obstetrics / Gynecology
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology/ENT (Ear/Nose/Throat)
- Pain / Anesthesia
- Pediatrics / Neonatology
- Pharmacology / Toxicology
- Podiatry
- Psychiatry
- Pulmonary
- Rare Disease
- Respiratory
- Rheumatology
- Sleep
- Surgery
- Thrombosis
- Urology
- Vaccines
- Women's Health
We believe the future of human health needs a fresh, future-focused approach. Founded in 2010, Accelagen was borne out of Greg and Rosa Plunkett’s passion and career as values-driven, outcome-focussed regulatory affairs and clinical development professionals.
From the outset, Accelagen has a demonstrated track record delivering services beyond a simple transaction. We focus on your end goal and design the right strategy to get you there faster, whilst contributing the out collective mission, to create a difference to the future of human health.
We challenge existing conventions to deliver commercially savvy and patient-centric outcomes for leading biopharmaceutical and medical device companies in the fast-growing global trials market across Australia, North America, Asia Pacific, and Europe. We offer strategic direction and consultation from concept through to commercialisation.
We prioritise understanding where you are on your journey and the broader context of impact you hope to have. Our process is collaborative and patient-centred. It draws upon our extensive industry experience and supports you to deliver a comprehensive and robust product to market, faster. It’s this unique and innovative approach that creates a marked difference in the outcomes we generate for you.